How to Interpret a Diffusion Capacity of the Lung for Carbon …
Mar 7, 2017 · The diffusion capacity of the lung for carbon monoxide (DLCO) is used to measure the body's ability to transfer oxygen across the alveolar-capillary membrane. [1] Internists use …
Phenotypic Shift, Varied Vasculopathy Noted in IPAH - Medscape
Jul 26, 2024 · In the current study, "a DLCO of < 45% almost perfectly identified patients with nonplexiform vasculopathy with prominent pulmonary microvascular disease," they said.
ERS/ATS Lung Guidelines Endorse Global Lung Initiative
Nov 28, 2022 · Despite unresolved questions about the impact of race/ethnicity on lung function, the GLI explains a large portion of the variability in lung function testing.
Long-COVID Patients Show Abnormal Lung Perfusion Despite …
Sep 12, 2024 · A study found abnormal lung perfusion in long-COVID patients with normal CT scans, highlighting pulmonary vascular issues. At ERS 2024, researchers call for further …
DLco, Pulmonary Hypertension, and Idiopathic Pulmonary Fibrosis
Apr 12, 2007 · Can diffusion capacity be used as a measure of pulmonary hypertension in patients with idiopathic pulmonary fibrosis?
Preoperative Evaluation of the Lung Cancer Resection Candidate
The ERS/ESTS guidelines state that DLCO should be routinely measured during preoperative evaluation of lung resection candidates, regardless of whether the spirometric evaluation is …
Lung Abnormalities Persist 3 Years After Severe COVID-19
Jul 18, 2025 · More than half of severe COVID-19 survivors show fibrotic-like lung abnormalities even 3 years after infection, especially those who are more critically ill.
Upadacitinib Outperforms Mycophenolate in SSc-ILD Treatment
Jun 13, 2025 · The change in DLCO (as a percentage of the predicted value) at 52 weeks was -62.7 mL in the upadacitinib group and -93.3 mL in the mycophenolate group.
Evolving Pulmonary Care Strategies for Lung Cancer Patients
Jul 18, 2025 · From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions continue to assist pulmonologists.
Serum IFN Score May Predict Outcome in Diffuse Cutaneous SSc
Apr 8, 2025 · Serum type I interferon scores may help identify patients with diffuse cutaneous systemic sclerosis with higher disease activity and poorer prognosis.